Unity Biotechnology
Biotechnology company focused on developing therapeutics for age-related diseases.
About
Technology stack
detected 2026-06-15“Unity Biotechnology, Inc. terminated its lease agreement, set to expire on December 31, 2029, with the Early Termination Date of March 31, 2026, and will pay $3.65M. The company also filed a certificate of dissolution on September 26, 2025,…”
View on Reddit“Unity Biotechnology Shuts Down - Best Breaking News.”
View on Reddit“Bay Area biotech company lays off every single worker, including CEO [Unity Biotechnology].”
View on Reddit“In blow to anti-aging field, Unity Biotechnology fails first major study, cuts lead program.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.
What does Unity Biotechnology do?
Unity Biotechnology was a biotechnology company focused on developing therapeutics for age-related diseases. Their primary approach involved targeting cellular senescence, aiming to clear out 'zombie' cells that contribute to inflammation and age-related damage. They conducted clinical trials for osteoarthritis and an age-related eye condition. However, the article indicates disappointing results from these trials, leading to significant layoffs and the company's closure. (formerly [].)
How much funding has Unity Biotechnology raised?
Unity Biotechnology has raised a total of $200M in funding. The most recent round on record is Series C.
Where is Unity Biotechnology headquartered?
Unity Biotechnology is headquartered in South San Francisco, California, USA.
When was Unity Biotechnology founded?
Unity Biotechnology was founded in 2014.
What industry does Unity Biotechnology operate in?
Unity Biotechnology operates in Biotechnology, Healthcare, Life Sciences, Drug Discovery, Biotech, MedTech.
How many employees does Unity Biotechnology have?
Unity Biotechnology has approximately 19 people on record.